INTRODUCTION
============

Mapping between genotype and phenotype, and more specifically, understanding the landscape of fitness over the complete set of theoretically possible genotypes ('genotypic sequence space') is a key and longstanding challenge across the biosciences ([@B1]). Such landscapes are typically very large and potentially complex ([@B2]). Questions about genotype--phenotype mapping are most acute, and potentially most tractable, when genotype and phenotype are very closely allied, i.e. fitness is determined directly by the primary nucleotide sequence, without mediation by transcription or translation. Thus models have recently been developed for nucleosome positioning ([@B3]) and transcription factor binding ([@B4]) *in vivo* and *in vitro*, respectively. However, the most insightful and comprehensive fitness landscape work has been carried out in theory ([@B5]) and *in silico*, notably with nucleic acid structure prediction ([@B6],[@B7]). The success of such *in silico* structure systems comes from the ability to carry out evolutionary computing experiments which explore otherwise intractably large regions of sequence space ([@B8]). For instance, a 30 nt sequence, as used here, lies within a landscape of 4^30^≈10^18^ possible sequences. Even with the smallest standard 5 μm microarray features, a 29 km^2^ array would be needed to assay them all *in vitro*. Here, we combine powerful aspects of an *in silico* evolutionary approach with an *in vitro* system to explore and characterize the sequence-fitness landscape for a specific bio-molecular interaction.

Aptamers are nucleic acids selected to bind particular target molecules ([@B9],[@B10]). Though small, they can form complex structures, with or without their target molecule ([@B11],[@B12]). Typically, aptamers are identified within sequence space via an evolutionary process (SELEX) ([@B9],[@B10]) involving sequential rounds of *in vitro* selection from a large pool, possibly including some mutation ([@B13]). The variety of sequences and structures and the population dynamics can be complex ([@B14],[@B15]); yet this 'black-box' process typically yields only a small number of known aptamer sequences at the end, and hence little information on the sequence-fitness landscape. In contrast, we assay known DNA sequences for aptameric binding using bespoke microarrays ([@B16]). On the basis of fitness values measured in the *in vitro* assay, selection and mutation of aptamer sequences is carried out explicitly, *in silico* ([@B17]) using known sequences at each generation. This yields a more directed, diverse and transparent evolution. To demonstrate our approach, that we call Closed Loop Aptameric Directed Evolution (hereafter CLADE, [Figure 1](#F1){ref-type="fig"}), we choose as our binding target a large (110 kDa) fluorescent protein, allophycocyanin (APC). APC is an important fluorescent reagent widely used in drug discovery. Aptamers to such fluorescent proteins, as developed here, have great potential application in protein localization *in vivo* ([@B18]). More generally, proteins are important targets for specific binding to aptamers, offering the potential for protein-binding arrays ([@B19]), with many advantages over alternative technologies such as antibodies ([@B20],[@B21]). Figure 1.Schematic of the CLADE approach. CLADE as utilized in this study starts at the top of the schematic with an initial choice of DNA sequences. These sequences may be generated entirely *in silico*, or optionally, as with some of the sequences here, utilizing prior knowledge generated *in vitro*. These sequences are synthesized on a custom microarray and bound with the chosen ligand, here the APC protein. Analysis of binding intensities gives a distribution of fitnesses; the frequency distribution of Generation 1 binding to APC protein is shown by way of example. Some of these sequences are selected *in silico*, based on the *in vitro* score distribution, here using tournament selection (see Materials and methods section). These sequences are then mutated *in silico* to generate a new sequence set which can then be synthesised *in vitro*, and so on round the cycle as often as is required. The final aptamer set offers a greatly increased binding affinity to the ligand.

This study comprises two conceptually separate parts: (i) The evolution of DNA aptamers to the APC protein using the CLADE *in vitro*, *in silico* approach; (ii) The analysis and modelling of the sequence-fitness landscape for these aptamers. These are respectively the subjects of the first two sections of the results. The first could be carried out without the second and, in principle, given an appropriate dataset from another source, the second could be carried out without the first. These parts are however connected in that it is only the large number of sequence-fitness pairs that explore the landscape in an efficient way, as generated by CLADE, that enable effective modelling of such a landscape. Further, an important feature of CLADE is that it can incorporate prior knowledge into aptamer generation ([Figure 1](#F1){ref-type="fig"}) and combining CLADE with modelling, as in this study, is itself one way to generate appropriate 'prior knowledge'. Incorporating prior knowledge into CLADE is the subject of the third section of the results. Doing so enhances the CLADE process both in creating potentially useful aptamers and in generating understanding of a sequence-fitness landscape.

MATERIALS AND METHODS
=====================

Array synthesis and binding
---------------------------

Six thousand 30 nt DNA sequences were synthesized in duplicate on Combimatrix B3 synthesizer (for a detailed protocol see <http://www.combimatrix.com>). Briefly, each chip contains 12 544 spots onto which chosen sequences are synthesized electrochemically. A total of 544 spots are used for fabrication and quality control. The spatial position of each replicate of each aptamer sequence was randomized independently for each chip.

*In vitro* assays were performed in phosphate buffered saline (1× PBS = 0.15 M NaCl, 20 mM phosphate buffer, pH 5.4) at 37^°^C with 0.01 mg/ml APC protein. Prior to binding all chips were incubated with a pre-binding solution (5% BSA, 0.5% Tween 1× PBS) for 30 min at 37°C. Chips were incubated with the binding solution (APC 0.01 mg/ml, 1× PBS) for 1 h. After this the chips are washed five times in 1× PBS at room temperature and imaged immediately. Details of how the assay conditions were chosen are given in [Supplementary Methods](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1).

Absolute binding measurement
----------------------------

Absolute binding was assayed by Surface Plasmon Resonance (SPR) in a Biacore 3000 instrument. Two DNA sequences were taken from the aptamer evolution, a low binding-score sequence from the first generation (C1.0489, TTAAGGAATACATAGATTATATGGCAAGTT score 5.8 ± 0.1) and a high binding-score sequence from the final generation (G9.3415, ATCCCCCCCTCCCCTTATGTGCACCCGCAT score 12.6 ± 0.8). These sequences were synthesized with a 3′-biotin tag and immobilized on a streptavidin coated chip in adjacent flow cells, causing an increase in ∼1700 resonance units (RU) in each case. One blank flow cell consisting of streptavidin only (without aptamer) was used as the control. Solutions of APC in the buffer used for binding in the evolution were passed over all of the flow cells at 20 μl min^−1^ at 37°C, and in each binding cycle the chip was regenerated with glycine buffer pH 1.5. Binding curves for APC at 214, 97, 76, 53 and 31 nM are shown in [Figure 3](#F3){ref-type="fig"} for the final generation sequence. Each curve was blank subtracted using the control flow cell. Curves were fitted separately to the data for 'on' and 'off ' rates at each concentration using the BIA-evaluation 4.1 software. Figure 2.Evolution of binding scores. The left side shows the median score and 95% bootstrap confidence interval for 30-mer experimental probes in each generation (solid line) and the same for the 500 control sequences (dashed line). The right side shows the frequency distribution of all the binding scores in each generation. The spread of the score distributions generally increases (SD: G1 = 0.55, G2 = 0.6, G3 = 0.62, G4 = 0.73, G5 = 0.74, G6 = 0.78, G7 = 0.92, G8 = 0.92, G9 = 1.08). Scores are on an arbitrary scale based on a generalized log transform ([@B50]) of the raw intensity measurements. The raw scan of the median scoring sequence from each generation assayed side by side on a separate chip is shown on the top of the left panel. Figure 3.SPR data and fits for a high scoring DNA sequence (G9.3415, score 12.6 ± 0.8). SPR signal is expressed in resonance units (RU), arrows indicate event timings. All data have the values from a control, blank flow cell subtracted. The fitted curves give the results in [Table 1](#T1){ref-type="table"}. Following the injection of the regeneration buffer, the section at the end (following 2000s) is given to show the reconstitution of the surface to an SPR signal close to the original baseline. Table 1.Absolute binding via SPR values from the fits shown in Figure 3APC concentration (nM)'on rate' *k*~a~ (M^−1^s^−1^)'off rate' *k*~d~(s^−1^)Apparent dissociation constant *K*~D~ (M)2142.1E + 045.3E − 052.6E − 09972.1E + 044.3E − 052.0E − 09762.0E + 045.5E − 052.7E − 09533.6E + 046.1E − 051.7E − 09311.3E + 046.4E − 055.0E − 09[^3]

### Microarray analysis

Images were scanned at 5 μm resolution and any artefacts, damaged or obscured spots were excluded by visual inspection. Median intensity values were recorded for each spot. The principal systematic spatial effects we have identified on these chips are smooth spatial gradients. These were removed by normalizing median intensity values to a smooth surface fitted for each chip by means of a spatial general additive model (GAM) in which the degree smoothing is chosen as part of the fit ([@B22]) i.e. probe intensities were multiplied by the median value of the fitted surface divided by the surface value at the probe location. The mean-variance relationship in the data was then removed simultaneously with normalization to the same scale among chips within a generation by fitting a generalized log transform model ([@B23]). This yields data on a uniform, though arbitrary scale, where zero is below background binding levels. The resulting binding score estimates for each sequence were then averaged (first within, then between chips) to give a single score for each sequence. The error values quoted were calculated as the standard error (SE) among chips (i.e. the SE of the chip means for each sequence). Scores were then normalized to the preceding generation\'s scores as follows: A linear transformation was estimated by fitting a line (orthogonal regression, using observed variances) to the plot of scores in the new generation vs. scores in the preceding generation for all identical sequences appearing in both generations (control sequences and sequences selected but by chance not mutated, usually a total of around 1200 sequences). Test chip scores were placed back onto the same scale as that used for the chips in the evolution in a similar manner, but using the 500 control probes only. These 500 control sequences were chosen to represent as evenly as possible the range of binding seen in the course of the optimisation of assay conditions (see [Supplementary Methods](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1) for details).

Evolution
---------

The CLADE methodology comprises a repeated cycle of sequence synthesis, *in vitro* assay, *in silico* selection and *in silico* mutation ([Figure 1](#F1){ref-type="fig"}). G1 Sequences comprised the 500 controls and 5500 30-base (*L* = 30) sequences generated with an equal probability of each base at each position. Following the *in vitro* assay, selection in G1 was from all 6000 sequences; in later generations only non-control sequences were used. 5500 sequences were selected *in silico* by a 'tournament selection'. In each case, the best scoring of four sequences picked uniformly at random with replacement from the current generation of sequences was taken. Selected sequences were subjected to point mutations and insertion--deletion events (indels). Point mutation comprised replacement of a base by a base generated uniformly at random with a probability of *1/L* at each position. Indels were applied subsequently also with a probability of *1/L* at each position. Indels were effected by inserting a new base (equal probability of all four bases) at a given position, followed by deletion of a base at a random position. These new sequences were then synthesized on a microarray and the analytical binding process repeated for a total of nine generations, i.e. until G9 had been synthesized, assayed and scored.

In order to demonstrate the validity of the CLADE method, a relatively simple *in silico* evolutionary algorithm was used ([@B8]). Other operations, including recombination could be in principle included. Recombination might be expected to find peaks in the landscape more effectively, though that would depend upon the ruggedness of that landscape. Theoretical studies also suggest that alternative parameter settings, including higher mutation rates and higher selection pressures, may result in improved performance ([@B24]). Empirical validation of these findings will be the subject of further study.

Sequence analysis
-----------------

Three hundred and two candidate explanatory variables ([Supplementary Table 3](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1)) were extracted from each sequence. These comprised the frequency and median position of all single, double and triple base sequences, as well as 30 4-level factors for the particular base at each position and 29 16-level factors for each pair of bases in each position. Motifs characteristic of high or low scoring sequences were identified using MotifScanner v3.2 and associated software ([@B25]). Motifs were identified in two ways. Firstly, motifs were searched for using all the top and bottom scoring probes from each lineage. Motifs were identified in the top scoring probes, assuming a background model derived from the bottom scoring probes and vice versa. Lineages containing only a single probe or where the top and bottom probe scores differed by less than 0.1 were omitted. Secondly, only the top quartile of the top scoring probes in each lineage and the bottom quartile of the bottom scoring probes in each lineage were used to find motifs, the background model was derived from the G1 probes. In both cases, motifs length 4, 8 and 14 were searched for, using 100 separate runs of the software in each case. Similar motifs were merged and the best matches to all motifs identified in all sequences. Location and motif score for the best matches to each motif in each sequence were used as explanatory variables. The 5000 top-scoring examples of the motif were used to create the logo plot in [Figure 7](#F7){ref-type="fig"}. The assumed prior probability of finding a motif in each sequence was raised until a hit to all motifs was found in all sequences. In most, but not all, cases there was a clear demarcation in the distribution of motif scores between motif scores that were ∼0 and all others. In cases of a motif score of ∼0, no location value was used.

DNA structure was predicted using hybrid-ss-min (UNAFold) version 3.4 ([@B26]), using the DNA input mode with settings of 37°C and 0.58 M NaCl concentration (equivalent to the binding conditions used in the *in vitro* assays). Discrete descriptions of the minimum free energy structure comprising the number of loops, bulges, hairpins and unmatched regions were made using a simple parsing algorithm developed in-house.

The proportion of pairs of nucleotides not able to undergo base stacking was also included (i.e. pyramidine dinucleotides, T-T, T-C and C-C) to indicate an expected bendability ([@B27]).

Modelling
---------

Data preparation comprised removing one complete record that had a missing binding score followed by replacing missing values by the mode (for nominal variables) and the median for numerical variables. Regression of the binding score as a function of all 302 predictor was carried out using Breiman and Cutler\'s random forests™ for classification and regression ([@B28]). A forest of 200 trees was used with the single parameter *mtry* set to 100 (the integer value of the number of predictor variables divided by three), its default recommended value for regression.

When using the forest to make predictions on test data, missing values in the predictor variables were first replaced using the same method as for the training data.

Alternative models were also fitted using regression trees ([@B29]) and genetic programming ([@B30]). Results were very similar in each case (i.e. similar explanatory variables shown to be important), however random forests were chosen since they provided the highest correlation between observed and predicted scores when tested on subdivisions of the main data set (NB the choice of method was made entirely independently of the independent test set reported in [Figure 7](#F7){ref-type="fig"}).

Software
--------

Image analysis used Combimatrix Microarray Imager (<https://webapps.combimatrix.com/customarray/customarrayHome.jsp>). Data preparation and inspection used JMP 7.02 ([@B31]). Data normalization and analysis used R 2.6.0 ([@B32]), and the mgcv 1.3 ([@B22]) and VSN 3.3.1 ([@B23]) packages, the latter being part of the Bioconductor project ([@B33]). The randomForest ([@B28]) package v4.5 for R was used for modelling.

RESULTS
=======

On-chip aptamer evolution reveals a multimodal fitness landscape
----------------------------------------------------------------

The CLADE procedure ([Figure 1](#F1){ref-type="fig"}) was initiated with a population of 6000 30 nt DNA sequences synthesized in duplicate on a custom microarray. A total of 5500 of these were entirely random sequences (with an equal probability of each base at each position), while the remaining 500 were controls, repeated in each generation and chosen from a trial binding to have a range of binding to APC. A binding score to APC was assayed *in vitro* for each sequence. A new generation of 5500 sequences was then obtained by selection on the basis of the *in vitro* binding score followed by mutation *in silico* (see Materials and methods section). These new sequences were then synthesized on a microarray and the analytical binding process repeated.

Nine generations (G1--G9) of CLADE were completed, during which the population of aptamers evolved from low-scoring binding to consistent high-scoring binding ([Figure 2](#F2){ref-type="fig"} and [Supplementary Table 2](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1)). To relate the relative binding-score scale used to an absolute affinity scale, sequences from the top and bottom of the binding score scale were assayed in an independent, Surface Plasmon Resonance (SPR) system. This indicated that, even using a different assay method, the high-scoring sequence bound APC with high affinity, whereas the low-scoring sequence did not measurably bind APC (though it was still possible to estimate the rate of wash-off, [Supplementary Table 2](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1)). While not expecting a linear relationship between concentration and SPR signal, there are complexities in the binding, giving a reduction of the SPR signal at higher concentrations ([Figure 3](#F3){ref-type="fig"}). However, an assumption of simple 1:1 binding indicates that the top of the binding-score scale corresponds to an apparent disassociation constant (*K*~D~) for the high scoring sequence in the low nanomolar range ([Table 1](#T1){ref-type="table"} and [Figure 3](#F3){ref-type="fig"}), well within the range of aptamers developed by other means ([@B34]). Direct comparison of aptamers derived by the CLADE approach to those derived to the same ligand by other means is the subject of a separate study (M. Platt. *et al.*, Submitted for publication). The specificity of binding was tested by assaying binding on the microarray to DsRed, a structurally unrelated protein. While some binding was identified, the highest affinity APC binders all had low DsRed binding ([Figure 4](#F4){ref-type="fig"}). Figure 4.Binding by G7 sequences to APC and DsRed. Both scales are arbitrary, but the APC scale corresponds to that in [Figure 2](#F2){ref-type="fig"}. The majority of sequences exhibiting a high degree of binding to APC possess binding scores around 1 with DsRed, which corresponds to undetectable binding. While some binding to DsRed was identified, the highest affinity APC binders all have low DsRed binding.

[Figure 5](#F5){ref-type="fig"}A illustrates the way the population is made up of individual lineages and the way they vary in size through the course of the evolution \[see also [Supplementary Figure 8](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1) for the complex dynamics of lineage sizes, similar to that seen in *in vitro* studies ([@B15],[@B35])\]. How those lineages explore the sequence landscape is shown in [Figure 5](#F5){ref-type="fig"}B and C, also [Supplementary Figures 9 and 10](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1). Sequences do not, in general, fall very close to the 'average' surface of the landscape ([Figure 5](#F5){ref-type="fig"}C), however, much of the discrepancy comes from the representation of a highly multidimensional landscape in two or three dimensions (see [Supplementary 'Methods' and Supplementary Figure 11](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1)). It is nonetheless clear that the sequence-fitness landscape is complex, with at least two major fitness peaks in APC binding (left and right in [Figure 5](#F5){ref-type="fig"}B and C). This multimodality and a more general 'ruggedness' of the landscape is demonstrated explicitly by considering the relationship of sequences' distance from a peak in sequence space with how far below that peak their binding-score is ([Figure 6](#F6){ref-type="fig"}). Further information about the degree and nature of this ruggedness is revealed by considering the fitness differences in individual evolutionary steps ([Supplementary Figure 12](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1)). The average fitness change decreases with each subsequent generation, and within any individual lineage, the frequency distribution of beneficial mutations is typically roughly exponential, as might be expected from theory ([@B36]). Individual lineages vary greatly in the region and amount of the sequence space they explore ([Supplementary Figure 10](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1)), though for lineages that move away from their starting sequence, the average movement is generally towards the nearest main peak ([Figure 5](#F5){ref-type="fig"}C). Figure 5.Evolution and the fitness landscape. Scores in the *in vitro* assay are indicated by the same colour scale in all three panels. (**A**) Successful lineages. All aptamers with descendants in the final generation are shown. Each circle represents a single aptamer sequence; lines connect parent and offspring sequences. Node size as well as colour indicates each sequence\'s binding score. (**B**) All 44 131 sequences are shown. 2D location represents relationship of sequence as determined by multidimensional scaling (see [Supplementary 'Methods'](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1)), plotted in order from the lowest to highest scorers, so higher scoring points can obscure lower. Two example lineages are indicated. In each case, the red dot is the starting sequence, black arrows are mutations, orange dots are sequences in the penultimate generation of the lineage and the yellow dot is the highest scoring sequence in the lineage. (**C**) A smoothed fitness surface across all sequences on the same *x*- and *y*-axes as (B) but with score as the *z*-axis. Superimposed are 150 randomly picked lineages, with a ball indicating the starting sequence in G1 \[equivalent to a red dot in (B)\] and a line connecting it to the average position for all the probes in the penultimate generation of the lineage \[equivalent to an average of the orange dots in (B)\]. Balls without lines indicate sequences that did not have descendants in G3 or later. Figure 6.Multimodality and ruggedness in the sequence-fitness landscape. Relationship between sequence distance and score difference for all aptamers (**A**) Relative to the highest scoring sequence in the complete experiment (G9.3415), (**B**) Relative to the closer (in sequence space) of the top scoring sequence in the two major peaks in [Figure 5](#F5){ref-type="fig"}B and C (G9.3415 --- ATCCCCCCCTCCCCTTATGTGCACCCGCAT and G8.5150 ---ATAGGGGTTGGTTTGGGGGGGGGGATACTC). In each case the line is a cubic spline, stiffness λ = 100. The line in (B) is straighter than that in (A) indicating that these two peaks account for much of the multimodality in the sequence-fitness landscape.

Machine learning model captures the aptamer landscape
-----------------------------------------------------

A more stringent test of our understanding of the landscape is binding prediction. A Random Forest ([@B28]) is a machine learning model capable of non-linear regression without over-fitting, and so is suitable for characterizing multimodal landscapes such as that of [Figure 5](#F5){ref-type="fig"}. We summarized the sequences tested in terms of 302 explanatory variables (including the base at each position, the frequencies and average positions of single, doublets and triplets of base pairs, longer motifs and structural predictions, [Supplementary Table 3](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1)). These variables and the observed binding scores for all the aptamers were used to train a Random Forest to predict binding.

To test the effectiveness of the resulting model in describing the landscape, we created an entirely independent set of test sequences. First, the random forest was used to predict scores for 10^6^ sequences, each base independently selected uniformly at random. 5500 of these sequences were then picked across the range of predicted bindings. This set of sequences was synthesized and assayed *in vitro*. The test set included sequences with both high and low aptameric binding ([Figure 7](#F7){ref-type="fig"}A, [Supplementary Table 4](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1)). The scores predicted by the random forest explained 70% of the observed variance in binding to APC in this wholly separate test set ([Figure 7](#F7){ref-type="fig"}A and [Supplementary Table 4](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1)). This is a highly effective prediction for sequences that are entirely unrelated to those on which the model was trained. One could expect even better prediction for variations based more closely on the evolved sequences and indeed, the model, having a mean-square error of 0.115 (the 'out-of-bag error') explains 92% of the variance in the evolved sequences on which it was developed. Figure 7.Prediction of aptamer binding. (**A**) Observed versus predicted binding for 5500 test sequences. Colour intensity indicates the density of points. Red line indicates predicted = observed. Pearson correlation = 0.87. (**B**) Importance of the most explanatory variables in the random forest predictor of aptamer binding. Importance is defined as the decrease in node impurity attributable to these variables across the forest. The motif reflects a contiguous sequence found anywhere within the 30mer. (**C**) Information content logo of the motif referred to in (B). The overall height at each position represents the sequence conservation, within which the height of each symbol indicates the relative frequency of each nucleotide.

The importance of the different explanatory variables in the prediction is shown in [Figure 7](#F7){ref-type="fig"}B and [Supplementary Figure 13](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1). It is very possible that features of the sequence beyond the 302 used here could explain more of the variance \[other studies have used different DNA features for modelling sequence-function relationships e.g. ([@B3])\]. However, the most important features identified here are identified by other modelling approaches (see Materials and methods section) or indeed inspection ([Supplementary Table 2](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1)). It is notable that none of the metrics derived from secondary structure predictions has a high importance. It is not clear whether this is due to specific secondary structure truly being unimportant for these aptamers or an inability of the prediction approach used to identify secondary structures correctly in the chip-surface environment.

Prior knowledge can be incorporated in CLADE aptamer design
-----------------------------------------------------------

There is much prior knowledge that may be relevant to aptamer design, e.g. in terms of known structure-function relationships such as nucleic acid motifs that bind specific amino acids ([@B37]) or particular structural features with desirable properties ([@B38]), or complete existing aptamer sequences. Such knowledge may lead to particularly informative or interesting regions of the sequence-fitness landscape. Of the 500 control aptamers included as parents for the creation of G2, 255 were specifically generated using prior knowledge. 129, (the 'designed' set) were generated via an algorithm which balanced 40 structural and sequence features found in small molecule aptamers ([Supplementary Figure 14](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1), Supplementary 'Methods' and C.G. Knight *et al.* unpublished data), while 126 sequences (the 'quadruplex' set) were random sequences apart from the nucleotides required to form a guanine (G) quadruplex ([@B39]). A G-quadruplex is a structural feature dependent on appropriately positioned G residues, and is a characteristic of a known DNA aptamer that binds the protein thrombin ([@B11],[@B12]).

There was a striking contrast between fates in the evolution of the 'designed' and 'quadruplex' sets of sequences. The 129 'designed' set aptamers in G1 gave rise to 3707 sequences in G9. In contrast, from the 126 'quadruplex' set in G1, only a single aptamer remained in the final generation and that was predicted to have lost its quadruplex structure. The quadruplex aptamers perform poorly even in relation to random sequences---there being 2.3% as many quadruplex as random sequences in G1, but only 0.13% by G9. The poor performance of the quadruplex aptamers is consistent with the random forest model results in which the presence of a quadruplex sequence has a very low importance (299th of 302 explanatory variables) and the variables of high importance are very unlike G-quadruplex sequences ([Figure 7](#F7){ref-type="fig"}B). This result suggests that while important in DNA aptamers ([@B11],[@B12]), the G-quadruplex structural feature may not be of universal utility for protein-binding DNA aptamers and/or that there are additional features required to make a quadruplex-containing aptamer that could not easily be achieved from the starting set of sequences we used. The good performance in the evolution of the designed sequence set relative to the random and quadruplex sets suggests that there may be aspects of aptamer design that are common across very different substrates. The success of designed sequences is partly attributable to many of them already being close to the left-hand fitness peak ([Figure 5](#F5){ref-type="fig"}B and C) in the first generation.

DISCUSSION
==========

These experiments reveal a fitness landscape that is complex ([Figure 5](#F5){ref-type="fig"}B and C) yet very well captured by our predictive model: the correlation of observed versus predicted fitness for an entirely independent set of test sequences is remarkably high (0.87). The experiments are strictly limited to a single molecule (APC) interacting under very specific conditions with a very constrained form of molecule (DNA 30 mers). Even so, the effectiveness of the model is striking considering that even with nine generations of evolution we covered only ∼4 × 10^4^ sequences, which is a tiny proportion of available sequence space (∼10^18^ sequences). Further, protein-aptamer interactions are complex, potentially inducing structural changes within both molecules ([@B12]).

The way this surprising predictability is achieved, and hence clues to the nature of the genotype-fitness relationship in this system, is revealed by looking into the workings of the model. This also provides hypotheses for the physical basis of aptameric binding. The most important features that determine aptamer binding, as described by the model, concern C bases in the middle of sequences, such as the match to the motif shown in [Figure 7](#F7){ref-type="fig"}C. Such sequential Cs are not liable to π-stacking in single-stranded DNA which may aid flexibility of the sequences ([@B27]), a feature that is considered explicitly by the 'bend' variable that is also important in the random forest model ([Figure 7](#F7){ref-type="fig"}B). However, the evolution is by no means directed towards a C homopolymer. Firstly, the motif shown in [Figure 7](#F7){ref-type="fig"}C is not an approximation to a string of Cs---if a C homopolymer motif of the same length is scored, and the random forest refitted using the homopolymer motif instead of that in [Figure 7](#F7){ref-type="fig"}C, the homopolymer motif has only a quarter of the motif \'s importance in the model (data not shown). Secondly, the complexity of the landscape means that runs of Cs are neither necessary nor sufficient for high-scoring aptamers. For instance, sequence CACCGGGCCCCCCCCCCCCCCCACCACGCC (G2.3596) contains a string of 15 Cs (there is only one aptamer in the whole evolution with more), yet scores in the bottom 10% of aptamers overall. Conversely, the sequence ATCACACCAAACCTTTCTTCGATTAAGTCG (G6.5628), with no more than two adjacent Cs, scores in the top 10%. The other most important features in determining binding relate to the three bases at the 5′-end of the sequence (the 'position' variables). Even among these relatively simple variables, the model captures complex effects. For instance, a C base in position 2 can give good binding, but *only* in combination with 'A' in position 1 and 'C' or 'T' in position 3. The CLADE procedure used here thoroughly explores these variables, meaning that, by G9, most aptamers start with 'ATC', the sequence with the highest marginal effect ([Supplementary Figure 13](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1)). This 5′-motif is physically positioned away from the surface of the chip, potentially representing a particular recognition motif. This dependence of binding on specific sequence motifs rather than merely nucleotide composition or other general features are consistent with the known association of tight aptameric binding with sequences of high information content ([@B40]).

The insight into the sequence-fitness landscape ([Figure 5](#F5){ref-type="fig"}) and the ability to predict binding ([Figure 7](#F7){ref-type="fig"}) derive directly from the CLADE approach. However, this is not the only advantage to CLADE when compared with fully *in vitro* techniques such as SELEX and similar approaches ([@B41]). Specific and noteworthy features of CLADE include: unlike fully *in vitro* approaches, CLADE is not biased towards sequences favourable for PCR; there is no immobilization of the target ligand, which risks selecting aptamers which bind the immobilization matrix; different affinity ligands are produced from the same experiment \[this is possible but uncommon in SELEX ([@B42])\] providing affinities suited to a chosen target\'s concentration range; there is complete control of population sizes, selection and mutation techniques, which allows one to deal with (and indeed study) issues of founder effects, elitism and other pitfalls of evolutionary dynamics. The last of these offers scope to use sequence-changing operators that are not accessible to fully *in vitro* techniques, e.g. the use of arbitrary knowledge-based transformations, such as the introduction of particular motifs or palindromic sequences. Indeed external knowledge may be incorporated at any stage of CLADE. We have demonstrated the efficacy of incorporating diverse prior knowledge in the design of the initial population. Because CLADE does not use enzymes means that it is not confined to standard nucleic acid bases, nor to bases that are substrates for nucleic acid polymerization. Aptamers could equally easily be designed to include locked nucleic acids, peptide nucleic acids or non-biological bases, or indeed any other monomers, which may also be less subject to biological degradation if taken into an *in vivo* system. In this study, we have used a single binding assay. However, CLADE could equally be applied to the evolution of other traits such as enzymatic activities in ribozymes or for DNA computing ([@B43]). Different forms of multiplex assay, e.g. by mass spectrometry, may in the future allow the evolution of aptameric binding to different targets simultaneously, an approach that will be aided by increasing spot densities on custom microarrays and improvements in mass spectrometric imaging ([@B44]). None of these advantages come at the cost of speed since CLADE is quick: the automated sequence generation meant that we were able to perform one generation of CLADE, including the design, synthesis and analysis of microarrays, in 24 h.

The understanding we have gained of an aptameric landscape is a form of 'Quantitative Structure (or Sequence)-Activity Relationship' (QSAR, a term used in chemometrics). The CLADE approach could be extended in the way that other QSAR approaches have been, to use the connection between sequence and fitness, captured in our case by a random forest, in the process of the aptamer evolution itself. The use of models to accelerate the search process is well known in evolutionary computation ([@B45]) and has been used successfully in developing desirable enzymatic activities ([@B46]). Conversely, the model could be used to minimize binding when generating aptamers to a different target without recourse to *in vitro* counter-selection. In this regard, it is very important that the CLADE method 'sees' the low-binding sequences---compare the uniformity in colour (binding score) of [Figure 5](#F5){ref-type="fig"}A, which shows only sequences that make it through to the final generation (as might be assayed in an *in vitro* technique), with the broad colour/score range of [Figure 5](#F5){ref-type="fig"}B and C which include all the sequences assayed by CLADE. The model we developed is therefore particularly good at predicting, and hence generating, low-affinity binding sequences, as well as 'good' aptamers ([Figure 7](#F7){ref-type="fig"}A). Such minimization of cross-reactivity is a crucial factor if aptamer arrays for proteomics and metabolomics and their advantages of principle over much better established antibody technologies ([@B20],[@B21]) are to be realized. More generally, a number of targets for positive or negative selection can be handled simultaneously using *multiobjective* evolutionary algorithms ([@B47],[@B48]).

Mapping sequence-function landscapes for particular biomolecules as we have done here is of wide relevance, notably in the emerging discipline of synthetic biology ([@B49]). However, mutational landscapes and landscape concepts of sequence-fitness relationships extend much further among multi-molecule systems. For instance genomic landscapes of cancer ([@B50]) and landscapes of whole organism inclusive fitness ([@B51]), even 'landscapes of change' ([@B52]). For whole organisms, the landscape metaphor has conceptual limitations ([@B53]), is rarely adequately tested ([@B54]) and seldom extends back to the scale of the effects of specific genome changes ([@B55]). However, progress is being made in the theory of sequence-fitness relationships in whole organisms ([@B56]). At the same time there is an unprecedented ability to work with mutations generated at unknown locations in complete genomes via high throughput sequencing ([@B57]) and array based technologies ([@B58]). Thus it may soon be possible to apply similar approaches to those developed here to understanding the vast, multimodal sequence-fitness landscapes experienced by the complete genomes of evolving biological organisms.

SUPPLEMENTARY DATA
==================

[Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkn899/DC1) are available at *NAR* Online.
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